Literature DB >> 12207375

Biological and medical significance of calcium phosphates.

Sergey V Dorozhkin1, Matthias Epple.   

Abstract

The inorganic part of hard tissues (bones and teeth) of mammals consists of calcium phosphate, mainly of apatitic structure. Similarly, most undesired calcifications (i.e. those appearing as a result of various diseases) of mammals also contain calcium phosphate. For example, atherosclerosis results in blood-vessel blockage caused by a solid composite of cholesterol with calcium phosphate. Dental caries result in a replacement of less soluble and hard apatite by more soluble and softer calcium hydrogenphosphates. Osteoporosis is a demineralization of bone. Therefore, from a chemical point of view, processes of normal (bone and teeth formation and growth) and pathological (atherosclerosis and dental calculus) calcifications are just an in vivo crystallization of calcium phosphate. Similarly, dental caries and osteoporosis can be considered to be in vivo dissolution of calcium phosphates. On the other hand, because of the chemical similarity with biological calcified tissues, all calcium phosphates are remarkably biocompatible. This property is widely used in medicine for biomaterials that are either entirely made of or coated with calcium phosphate. For example, self-setting bone cements made of calcium phosphates are helpful in bone repair and titanium substitutes covered with a surface layer of calcium phosphates are used for hip-joint endoprostheses and tooth substitutes, to facilitate the growth of bone and thereby raise the mechanical stability. Calcium phosphates have a great biological and medical significance and in this review we give an overview of the current knowledge in this subject.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12207375     DOI: 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  213 in total

Review 1.  Calcium Phosphate Bioceramics: A Review of Their History, Structure, Properties, Coating Technologies and Biomedical Applications.

Authors:  Noam Eliaz; Noah Metoki
Journal:  Materials (Basel)       Date:  2017-03-24       Impact factor: 3.623

Review 2.  Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review.

Authors:  Susmita Bose; Solaiman Tarafder
Journal:  Acta Biomater       Date:  2011-11-20       Impact factor: 8.947

3.  Effect of hydrazine based deproteination protocol on bone mineral crystal structure.

Authors:  I A Karampas; M G Orkoula; C G Kontoyannis
Journal:  J Mater Sci Mater Med       Date:  2012-03-03       Impact factor: 3.896

4.  The predominant role of collagen in the nucleation, growth, structure and orientation of bone apatite.

Authors:  Yan Wang; Thierry Azaïs; Marc Robin; Anne Vallée; Chelsea Catania; Patrick Legriel; Gérard Pehau-Arnaudet; Florence Babonneau; Marie-Madeleine Giraud-Guille; Nadine Nassif
Journal:  Nat Mater       Date:  2012-07-01       Impact factor: 43.841

5.  Indirect rapid prototyping of biphasic calcium phosphate scaffolds as bone substitutes: influence of phase composition, macroporosity and pore geometry on mechanical properties.

Authors:  M Schumacher; U Deisinger; R Detsch; G Ziegler
Journal:  J Mater Sci Mater Med       Date:  2010-10-15       Impact factor: 3.896

6.  The role of prenucleation clusters in surface-induced calcium phosphate crystallization.

Authors:  Archan Dey; Paul H H Bomans; Frank A Müller; Julia Will; Peter M Frederik; Gijsbertus de With; Nico A J M Sommerdijk
Journal:  Nat Mater       Date:  2010-11-14       Impact factor: 43.841

7.  A novel method for the fabrication of homogeneous hydroxyapatite/collagen nanocomposite and nanocomposite scaffold with hierarchical porosity.

Authors:  Xinyu Shen; Li Chen; Xuan Cai; Tong Tong; Hua Tong; Jiming Hu
Journal:  J Mater Sci Mater Med       Date:  2010-12-14       Impact factor: 3.896

8.  MgNd2 alloy in contact with nasal mucosa: an in vivo and in vitro approach.

Authors:  R Eifler; J-M Seitz; C M Weber; S Grundke; J Reifenrath; M Kietzmann; T H Lenarz; H J Maier; C Klose; M Durisin
Journal:  J Mater Sci Mater Med       Date:  2015-12-24       Impact factor: 3.896

9.  In vivo evaluation of neutron capture therapy effectivity using calcium phosphate-based nanoparticles as Gd-DTPA delivery agent.

Authors:  Novriana Dewi; Peng Mi; Hironobu Yanagie; Yuriko Sakurai; Yasuyuki Morishita; Masashi Yanagawa; Takayuki Nakagawa; Atsuko Shinohara; Takehisa Matsukawa; Kazuhito Yokoyama; Horacio Cabral; Minoru Suzuki; Yoshinori Sakurai; Hiroki Tanaka; Koji Ono; Nobuhiro Nishiyama; Kazunori Kataoka; Hiroyuki Takahashi
Journal:  J Cancer Res Clin Oncol       Date:  2015-12-09       Impact factor: 4.553

Review 10.  The use of nanoparticulates to treat breast cancer.

Authors:  Xiaomeng Tang; Welley S Loc; Cheng Dong; Gail L Matters; Peter J Butler; Mark Kester; Craig Meyers; Yixing Jiang; James H Adair
Journal:  Nanomedicine (Lond)       Date:  2017-09-04       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.